How The Investment Narrative For Quest Diagnostics (DGX) Is Shifting With New Valuation Work
Quest Diagnostics Inc DGX
$186.61
▼ -0.71%
($-1.33)
Index member:
S&P 500
Open
$189.16
Prev Close
$187.94
Day Range
$186.43 – $189.88
52W Range
$164.65 – $213.50
Market Cap
$21.05B
P/E (TTM)
20.19
Beta
0.59
Div Yield
1.83%
EPS (TTM)
$9.08
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NEW YORK STOCK EXCHANGE, INC. |
| Currency | USD |
| IPO Date | 1996-12-17 |
| Shares Out. | 110,680,000 |
| Website | questdiagnostics.com/ ↗ |
| Phone | 13026587581 |
Quest Diagnostics Inc is a publicly traded company under the ticker symbol DGX on the NEW YORK STOCK EXCHANGE, INC., operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
24 analysts (2026-05-01)
📰 Latest News for DGX
Altria and 13 More Losing Stocks That Should Make a Comeback
Quest Diagnostics, Altria, and 12 More Stocks That Are Coming Back to Life After a Rough Patch
Oracle adds Cleveland Clinic CEO to board of directors
Labcorp expands Epic pact to make full test menu available on Aura
Tempus AI: My Pick For An Oncoming Boom In Demand For Data-Driven Precision Medicine
Drug Screening Market Research and Global Forecast Report 2026-2036: Increasing Demand in Various Sectors Such As Workplaces, Criminal Justice Systems, and Drug Treatment Centers
Bullish Quarterly Results: 3 Companies Raising Guidance